Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing observational study of Genvoya and Descovy in Chinese patients with HIV-1 infection
ChiCTR2000028825Phase 4Completed
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir alafenamide in Human immunodeficiency virus infection type 1, sponsored by Shanghai Public Health Clinical Center. Primary endpoints: Occurrence of adverse events and Treatment success. Started Aug 2019; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on ChiCTR2000028825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028825.